2013, Number 11
<< Back Next >>
Ginecol Obstet Mex 2013; 81 (11)
Acceptance of the vaccine against human papilloma virus from mothers to daughters aged 9 to 13 years old
Godoy-Verdugo MK, Zonana-Nacach A, Anzaldo-Campos MC
Language: Spanish
References: 17
Page: 645-651
PDF size: 148.53 Kb.
ABSTRACT
Background: If you consider that at some point in life 50% of
sexually active women have had an infection with the human
papilloma virus is indisputable that any attempt to reduce the
prevalence worth undertaking it. The vaccine to prevent HIV
infection has not enjoyed the same degree of acceptance than
others, hence the interest in knowing some of the reasons
that has not achieved universal vaccination.
Objective: To examine human papillomavirus (HPV) vaccine
acceptability among mothers with adolescents girls between
9 and 13 years old.
Methods: The mothers were interrogated about HVP vaccine
acceptability, reasons provided for acceptance or nonacceptance
and if mothers know that vaccine is offered free
for public health institutions.
Results: We interview a 250 mothers with 281 daughters,
38 daughters have already received the vaccine. Eighty nine
percent of the mothers reacted positively to the possibility
of vaccinating theirs daughters. The reasons of vaccine nonacceptance
were because not knowing enough about infection,
mother felt that their daughters were not at risk for acquiring
HVP infection, the vaccine is new and mothers unknown
side effects. Thirty nine percent of the mothers want to know
more about the vaccine safety, 21% about length protection
duration and 16% concerning about if the vaccine is effective.
Fifty seven per cent of the mothers know that Health Secretary
offers vaccine free. Mothers whom have been vaccinated their
daughters, had daughters with lower age (9.8 ± 0.9 vs 10.8 ± 1.3
years, p =0.0001), were more frequently married (79 vs 51 %,
p = 0.002) and more likely to report that they had heard about
VPH vaccine from some source (100 vs 66%, p= 0.0001) that
mothers have not yet vaccinated their daughters.
Conclusions: The acceptability of VPH vaccine was 89%.
Continued health education and propaganda is needed to
promote a better knowledge of VPH vaccine.
REFERENCES
Muñoz K, Bosh FX, De Sanjosé S, Talfur L, Izarzugaza I, Gili M, Viladin P, et al. The causal link between human papillomavirus and invasive cervical cancer: a population based case control study in Colombia and Spain. Int J Cancer 1992;52:743-749 .
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med 19983;338:423-428.
Juárez-Albarrán AC, Juárez Gómez CA. Vacuna contra el virus del papiloma humano. Rev Med Inst Mex Seguro Soc 2008;46:631-637.
Baseman JG, Koutusky LA. The epidemiology of human papillomavirus infection. J Clin Virol 2005;32(suppl): 516-524.
Markowitz LE, Dume EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recom Rep 2007;56(RR-2):1-24.
Lazcano-Ponce E, Salmerón-Castro J, García-Carrancá A, Aranda-Flores C, Madrid-Marina V, Gómez- Altamirano CM, et al. Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization. Salud Pública Mex 2009;51:336-341.
Lazcano-Ponce E, Rivera L, Arillo-Santillán E, Salmerón J, Hernández-Ávila M Muñoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Archives of Medical Research 2001;32:243-247.
Olshen E, Woods RE, Austin BS, Luskin M, Baucner H. Parenteral acceptance of the human papillomavirus vaccine. J Of Adolescent Health 2005;37:248-251.
Constantine NA, Jerman P. Acceptance of Human Papillomavirus Vaccination among Californian Parents of Daughters: A Representative Statewide Analysis. Journal of Adolescent Health 2007;40:108-115.
Kahn JA. Maximizing the Potential Public Health Impact of HPV Vaccines: a focus on parents. J Adolesc Health 2007;40:101-103.
Dempsey AF, Zimet GD, Davis RL, Kousky L. Factors that are associated with parental acceptance of human papillomavirus vaccine: a randomized intervention study of written information about HPV. Pediatrics 2006;117:486-493.
Waller J, Marlow LA, Wardler J. Mother`s attitudes toward preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006;15:257-261.
Brabin L, Roberts SA, Farzameh F, Kitchner HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006;24:3087-3094.
Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10 to 15 year old adolescents. J Low Genit Tract Dis 2004;8:188-194.
Tozzi EA, Rava DL, Pandolfi E, Marino GA, Ugazio GA. Attitudes towards HVP immunization of Italian mothers of adolescents girls and potential role of health professionals in the immunization program. Vaccine 2008;27:2625-2629.
Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010;4:e1000270.
Dempsey AF, Mendez D. Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate. J Adolesc Health 2010;7:242-248.